Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Yasuo Urata"'
Autor:
Takanori Oyama, Hiroshi Tazawa, Hiroshi Nouso, Yasuo Urata, Takuo Noda, Toshiyoshi Fujiwara, Morimichi Tani, Terutaka Tanimoto, Takeshi Ieda, Shunsuke Kagawa
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 14-23 (2020)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Neuroblastoma (NB) is a primary malignant tumor of the peripheral sympathetic nervous system. High-risk NB is characterized by MYCN amplification and human telomerase reverse transcriptase (hTERT) rearrangement, contributing to hTERT activation and a
Autor:
Satoru Kikuchi, Motoyasu Tabuchi, Wataru Ishikawa, Toshihiro Ogawa, Kazuhiro Noma, Shunsuke Kagawa, Yasuo Urata, Masahiko Nishizaki, Shinji Kuroda, Hiroshi Tazawa, Toshiyoshi Fujiwara
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 262-271 (2020)
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 262-271 (2020)
Peritoneal metastasis is the most frequent form of distant metastasis and recurrence in gastric cancer, and the prognosis is extremely poor due to the resistance of systemic chemotherapy. Here, we demonstrate that intraperitoneal (i.p.) administratio
Autor:
Toshiyoshi Fujiwara, Ryohei Shoji, Takeshi Koujima, Hiroshi Tazawa, Yasuo Urata, Takeshi Ieda, Hiroyuki Mizuguchi, Ryuichi Yoshida, Hiroyuki Araki, Satoru Kikuchi, Shinji Kuroda, Takuro Fushimi, Fuminori Teraishi, Yuzo Umeda
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 17, Iss, Pp 107-117 (2020)
Molecular Therapy: Oncolytics, Vol 17, Iss, Pp 107-117 (2020)
Pancreatic ductal adenocarcinoma (PDAC) cells have an exceptional ability to invade nerves through pronounced crosstalk between nerves and cancer cells; however, the mechanism of PDAC cell invasion remains to be elucidated. Here, we demonstrate the t
Autor:
Yasuhiro Shirakawa, Yasuo Urata, Susumu Kanazawa, Shunsuke Tanabe, Shinji Kuroda, Takeshi Koujima, Kuniaki Katsui, Satoru Kikuchi, Shunsuke Kagawa, Nobuhiko Kanaya, Hajime Kashima, Kazuhiro Noma, Takuya Kato, Toshiyoshi Fujiwara, Hiroshi Tazawa
Publikováno v:
European journal of cancer (Oxford, England : 1990). 153
Purpose: OBP-301 (Telomelysin) is an attenuated type-5 adenovirus that contains the human telomerase reverse transcriptase promoter to regulate viral replication. OBP-301 sensitises human cancer cells to ionising radiation by inhibiting DNA repair, a
Autor:
Atene Ito, Toshiyoshi Fujiwara, Shunsuke Kagawa, Shinji Kuroda, Kazuya Kuwada, Hiroshi Tazawa, Hiroyuki Kishimoto, Megumi Watanabe, Yasuo Urata, Michihiro Ishida, Kunitoshi Shigeyasu, Shuta Tomida, Yuuri Hashimoto, Ryuichi Yoshida, Shuichi Sakamoto, Satoru Kikuchi
Publikováno v:
Cancer Science
Gastric cancer patients positive for peritoneal cytology are at increased risk of tumor recurrence, but although a certain proportion of cytology‐positive patients relapse rapidly with aggressive progression, others survive longer with conventional
Autor:
Yasuaki Yamakawa, Toshiyuki Kunisada, Shunsuke Kagawa, Yusuke Mochizuki, Joe Hasei, Toshifumi Ozaki, Toshinori Omori, Aki Yoshida, Shuhei Osaki, Kazuhisa Sugiu, Tomohiro Fujiwara, Koji Ueda, Hiroya Kondo, Toshiyoshi Fujiwara, Hiroshi Tazawa, Yasuo Urata, Tadashi Komatsubara
Publikováno v:
Cancer chemotherapy and pharmacology. 88(3)
Background Osteosarcoma (OS) is a malignant bone tumor primarily affecting children and adolescents. The prognosis of chemotherapy-refractory OS patients is poor. We developed a tumor suppressor p53–expressing oncolytic adenovirus (OBP-702) that ex
Autor:
Atsushi Mukai, Yuji Yamamoto, T. Ikushima, Yasuo Urata, Chie Sotozono, Junji Hamuro, Shigeru Kinoshita, Morio Ueno
Publikováno v:
Scientific Reports
Inhibition of fibrosis is indispensable for maintaining filtering blebs after glaucoma filtration surgery (GFS). The purpose of this study was to investigate the ability of a pluripotent epigenetic regulator OBP-801 (OBP) to ameliorate extracellular
Autor:
Kentaro Suina, Yukiko Namba, Shunsuke Kato, Moe Iwai, Tetsutaro Nagaoka, Fuminori Sakurai, Hiroaki Motomura, Issei Sumiyoshi, Junko Watanabe, Toshimasa Uekusa, Takafumi Mizuno, Kanae Abe, Takuo Hayashi, Yasuo Urata, Shinichi Sasaki, Kotaro Kadoya, Shinsaku Togo, Kazuhisa Takahashi, Hiroyuki Mizuguchi
Publikováno v:
Oncotarget
Anti-anaplastic lymphoma kinase (ALK)-targeted therapy dramatically improves therapeutic responses in patients with ALK-rearranged lung adenocarcinoma (Ad-LC). A few cases of squamous cell lung carcinoma (Sq-LC) with ALK rearrangement have been repor
Autor:
Hideki Hayakawa, Takeshi Obata, Yasunari Mizumoto, Kyosuke Kagami, Rena Yamazaki, Takashi Iizuka, Mitsuhiro Nakamura, Yukiko Bono, Toshiyoshi Fujiwara, Subaru Myojyo, Fuminori Sakurai, Masahiro Takakura, Jyunpei Iwadare, Toshiyuki Sasagawa, Takeo Matsumoto, Hiroyuki Mizuguchi, Yasuo Urata, Satoru Kyo, Kentaro Nakayama, Shunsuke Orisaka, Hiroshi Fujiwara
Publikováno v:
Cancer Science
Circulating tumor cells (CTC) are newly discovered biomarkers of cancers. Although many systems detect CTC, a gold standard has not yet been established. We analyzed CTC in uterine cervical cancer patients using an advanced version of conditionally r
Autor:
Joe Hasei, Toshifumi Ozaki, Yasuaki Yamakawa, Yasuo Urata, Toshiyoshi Fujiwara, Shunsuke Kagawa, Tadashi Komatsubara, Aki Yoshida, Kazuhisa Sugiu, Shuhei Osaki, Hiroshi Tazawa, Kouji Uotani, Toshinori Omori, Toshiyuki Kunisada, Tomohiro Fujiwara
Publikováno v:
Cancer Science
Osteosarcoma is an aggressive malignant bone tumor that causes bone destruction. Although tumor-specific replicating oncolytic adenovirus OBP-301 induces an antitumor effect in an osteosarcoma tumor, it cannot prevent bone destruction. Zoledronic aci